JPRN-UMIN000044535
Suspended
未知
A Biomarker Study Using Tumor-infiltrating Regulatory T Cells to Predict the Efficacy to Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer and Malignant Melanoma - A Biomarker study of ICIs for non-small cell lung cancer and malignant melanoma
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Hematology, Oncology and Respiratory Medicine0 sites130 target enrollmentSeptember 1, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-Small Cell Lung Cancer or Malignant Melanoma
- Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Hematology, Oncology and Respiratory Medicine
- Enrollment
- 130
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A biomarker study using tumor-infiltrating lymphocytes in patienst with biliary tract cancerBiliary tract cancerJPRN-UMIN000052526Okayama University70
Completed
Not Applicable
tudy on Biomarkers Using Circulating Tumor Cells When Administering Osimertinib in Patients with EGFR Mutation-positive Lung CancerJPRN-UMIN000032055Toho University50
Terminated
Phase 1
Exploratory Phase Ib/IIa Study of Intratumourally Administered Tigilanol Tiglate to Assess Safety, Tolerability and Tumour Response in Patients with Head and Neck Squamous Cell CarcinomaACTRN12619001407189QBiotics Group Limited19
Unknown
Phase 1
To study the Safety, Tolerability and Tumour Response when treated with drug Tigilanol Tiglate administered intratumourally in Patients with Head and Neck Squamous Cell Carcinoma.Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2019/11/022032QBiotics Group Limited13
Recruiting
Not Applicable
Exploratory biomarker study on tumor microenvironment using pre-treatment and refractory archival samples of hepatocellular carcinomaJPRN-UMIN000047701Chiba University Hospital60